Cal-Maine Foods exceeded expectations in Q2 thanks to strong demand and strategic positioning, despite challenges with feed costs and market volatility.

Cal-Maine Foods shares climbed Wednesday after the egg producer reported better-than-expected results on higher egg prices and holiday season demand.

Cal-Maine Foods’s stock rose about 5% after hours as the nation’s largest egg producer reported stronger-than-expected quarterly profits despite [bird flu roiling the sector](

Cal-Maine Foods, Inc. (NASDAQ: CALM) is the largest producer and distributor of fresh shell eggs in the United States, and it presents a compelling investment case in the current market. As a dominant player in a defensive,

U.S. equites were slightly lower at midday as the market weighed the latest report on private sector employment and waited for the government's jobs report later this week.

Cal-Maine shares hold a bullish outlook following today’s healthy earnings and a tailwind from the stock’s strong technical trends. Investors should target a continuation of the rally to a price target of $130.

Cal-Maine Foods (NASDAQ:CALM) is scheduled to announce Q2 earnings results on Tuesday, January 7th, after market close. The consensus EPS Estimate is $4.25 (+1114.3% Y/Y) and the consensus Revenue Estimate is $751.

According to the latest USDA report from mid-December, US egg production is down 4% year over year, with 3% fewer egg-laying hens. Per DataAssembly, eggs are at their highest price since January 2023.

Hoth Therapeutics, Inc. HOTH shares tumbled 22.4% to $1.77 in pre-market trading. Hoth Therapeutics shares jumped 178% on Tuesday after the company announced safety results from its Phase 2a trial, showing that 100% of patients in Cohort 1 achieved the primary efficacy endpoint.

Cal-Maine's growth is fueled by higher egg prices, but the boost is temporary. Find out why CALM stock may be undervalued at around $29 per share.